These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15791618

  • 1. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11.
    Hayashi H, Takada T, Suzuki H, Akita H, Sugiyama Y.
    Hepatology; 2005 Apr; 41(4):916-24. PubMed ID: 15791618
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
    Kagawa T, Watanabe N, Mochizuki K, Numari A, Ikeno Y, Itoh J, Tanaka H, Arias IM, Mine T.
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
    [Abstract] [Full Text] [Related]

  • 4. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
    Hayashi H, Sugiyama Y.
    Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
    [Abstract] [Full Text] [Related]

  • 5. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
    Lam P, Pearson CL, Soroka CJ, Xu S, Mennone A, Boyer JL.
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
    Noe J, Kullak-Ublick GA, Jochum W, Stieger B, Kerb R, Haberl M, Müllhaupt B, Meier PJ, Pauli-Magnus C.
    J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
    [Abstract] [Full Text] [Related]

  • 8. Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2.
    Misawa T, Hayashi H, Sugiyama Y, Hashimoto Y.
    Bioorg Med Chem; 2012 May 01; 20(9):2940-9. PubMed ID: 22464344
    [Abstract] [Full Text] [Related]

  • 9. Short- and medium-chain fatty acids enhance the cell surface expression and transport capacity of the bile salt export pump (BSEP/ABCB11).
    Kato T, Hayashi H, Sugiyama Y.
    Biochim Biophys Acta; 2010 Sep 01; 1801(9):1005-12. PubMed ID: 20398791
    [Abstract] [Full Text] [Related]

  • 10. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
    Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerová D, Rayner A, Dutton L, Meier Y, Antoniou A, Stieger B, Arnell H, Ozçay F, Al-Hussaini HF, Bassas AF, Verkade HJ, Fischler B, Németh A, Kotalová R, Shneider BL, Cielecka-Kuszyk J, McClean P, Whitington PF, Sokal E, Jirsa M, Wali SH, Jankowska I, Pawłowska J, Mieli-Vergani G, Knisely AS, Bull LN, Thompson RJ.
    Gastroenterology; 2008 Apr 01; 134(4):1203-14. PubMed ID: 18395098
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing.
    Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, Mieli-Vergani G, Thompson RJ.
    Hepatology; 2009 Feb 01; 49(2):553-67. PubMed ID: 19101985
    [Abstract] [Full Text] [Related]

  • 15. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency.
    Felzen A, van Wessel DBE, Gonzales E, Thompson RJ, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, Czubkowski P, Rock N, Shagrani M, Broering D, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Polat E, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsőfi A, Calvo PL, Grabhorn E, Hartleif S, van der Woerd WJ, Kamath BM, Wang JS, Li L, Durmaz Ö, Kerkar N, Jørgensen MH, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Ferreira CT, Guerrero FO, Wang H, Sency V, Kim KM, Chen HL, de Carvalho E, Fabre A, Bernabeu JQ, Zellos A, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Horslen S, Schwarz K, Bezerra JA, Wang K, Hansen BE, Verkade HJ, NAtural course and Prognosis of PFIC and Effect of biliary Diversion (NAPPED) Consortium.
    JHEP Rep; 2023 Feb 01; 5(2):100626. PubMed ID: 36687469
    [Abstract] [Full Text] [Related]

  • 16. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E, Grosse B, Schuller B, Davit-Spraul A, Conti F, Guettier C, Cassio D, Jacquemin E.
    Hepatology; 2015 Aug 01; 62(2):558-66. PubMed ID: 25716872
    [Abstract] [Full Text] [Related]

  • 17. Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.
    Mareux E, Lapalus M, Amzal R, Almes M, Aït-Slimane T, Delaunay JL, Adnot P, Collado-Hilly M, Davit-Spraul A, Falguières T, Callebaut I, Gonzales E, Jacquemin E.
    Liver Int; 2020 Aug 01; 40(8):1917-1925. PubMed ID: 32433800
    [Abstract] [Full Text] [Related]

  • 18. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
    Harris MJ, Kagawa T, Dawson PA, Arias IM.
    J Gastroenterol Hepatol; 2004 Jul 01; 19(7):819-25. PubMed ID: 15209631
    [Abstract] [Full Text] [Related]

  • 19. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
    Gonzales E, Grosse B, Cassio D, Davit-Spraul A, Fabre M, Jacquemin E.
    J Hepatol; 2012 Sep 01; 57(3):695-8. PubMed ID: 22609309
    [Abstract] [Full Text] [Related]

  • 20. Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone.
    Gan L, Pan S, Cui J, Bai J, Jiang P, He Y.
    Mol Med Rep; 2019 Jan 01; 19(1):195-204. PubMed ID: 30431138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.